Pillstats
Rx only · Injection, Solution · Intramuscular

Furosemide

Furosemide

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03CA01
RxCUI (US)4603
US makers12 labelers
Packages53
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.109$0.219$0.328$0.438Jul 2025Mar 2026Jul 2026
$0.361
Latest avg · Jul 22, 2026
+62%
Since Jul 23, 2025
12
Active US suppliers
32%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.8K7.5K11K15K2025 Q12025 Q22025 Q32025 Q42026 Q1
7.5K
Rx · 2026 Q1
40K
Units dispensed
-42%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
HF Acquisition Co LLC, DBA HealthFirstunknown11SUPPLYING
Sagent Pharmaceuticalsunknown6SUPPLYING
Fresenius Kabi USA, LLCunknown6SUPPLYING
Hospira, Inc.unknown6SUPPLYING
Gland Pharma Limitedunknown6SUPPLYING
Meitheal Pharmaceuticals Inc.unknown5SUPPLYING
Cardinal Health 107, LLCunknown4SUPPLYING
Avenacy, LLCunknown3SUPPLYING
Eugia US LLCunknown3SUPPLYING
Henry Schein Inc.unknown1SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING
Phlow Corporationunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 7, 2020
    SHORTAGEDrug shortage: Furosemide Injection (Meitheal Pharmaceuticals, Inc.)

    Furosemide Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Cardiovascular.

  • Apr 7, 2020
    SHORTAGEDrug shortage: Furosemide Injection (Gland Pharma Limited)

    Furosemide Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Cardiovascular.

  • Apr 7, 2020
    SHORTAGEDrug shortage: Furosemide Injection (Eugia US LLC)

    Furosemide Injection — reported in shortage by Eugia US LLC. Therapeutic category: Cardiovascular.

  • Apr 7, 2020
    SHORTAGEDrug shortage: Furosemide Injection (Hospira, Inc., a Pfizer Company)

    Furosemide Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.

  • Apr 7, 2020
    SHORTAGEDrug shortage: Furosemide Injection (Fresenius Kabi USA, LLC)

    Furosemide Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Cardiovascular.

  • Feb 26, 2013
    RECALLRecall (Class II): Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 US…

    Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico

  • Jan 10, 2013
    RECALLRecall (Class II): Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-610…

    Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial — Recalling firm: Hospira, Inc. — Nationwide